Low SVR rates in clinical practice for treating genotype 1 chronic hepatitis C with protease inhibitors boceprevir and telaprevir

Dig Dis Sci. 2015 Jan;60(1):272-4. doi: 10.1007/s10620-014-3374-1. Epub 2014 Oct 5.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Female
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Male
  • Oligopeptides / therapeutic use*
  • Proline / analogs & derivatives*

Substances

  • Antiviral Agents
  • Oligopeptides
  • Proline